Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 7Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Burkitt Lymphoma 4Ovarian Neoplasms 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Lung Neoplasms 2Head and Neck Neoplasms 2Xerostomia 1Thyroid Carcinoma, Anaplastic 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non Small Cell Lung Cancer 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Osteosarcoma 1Neutropenia 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Myeloma 1

Interventions

Temozolomide 11Radiotherapy 11Filgrastim 6Granulocyte Colony-Stimulating Factor 4Chemotherapy, Adjuvant 4etoposide phosphate 3Topotecan 3O(6)-benzylguanine 3Melphalan 3Etoposide 3Cyclophosphamide 3Carboplatin 3sodium thiosulfate 2sargramostim 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Methylphenidate 2Mannitol 2Ifosfamide 2Carmustine 2Busulfan 2Bone Marrow Transplantation 2Bevacizumab 2transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1temsirolimus 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1poly ICLC 1pentetreotide 1pemigatinib 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Central Nervous System Neoplasms × pegfilgrastim × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡